Anthropic IPO raise reportedly to exceed SpaceX's record haul
Published 1 d ago4 sourcesEvidence: Reported
Yicura BioMed, a Hong Kong Science Park biotech, plans an IPO in the city as soon as practicable, CEO Xian Jin said. Jin argues Hong Kong's biotech ecosystem lacks patient capital and commercialization talent, a recurring theme for the sector. The IPO signals continued but cautious capital-market activity in Hong Kong biotech.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Published 1 d ago4 sourcesEvidence: Reported
Published 1 d ago5 sourcesEvidence: Reported
Published 22 h ago3 sourcesEvidence: Reported
Published 18 h ago3 sourcesEvidence: Reported
Published 1 d ago2 sourcesEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported